-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Ascentage Pharma Group International FDA And EMA Clear Phase Iii Study Of Lisaftoclax For Hr-Mds

Reuters·08/18/2025 01:17:12

Please log in to view news